124 related articles for article (PubMed ID: 21868360)
1. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
[TBL] [Abstract][Full Text] [Related]
2. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
Korpal M; Lee ES; Hu G; Kang Y
J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277
[TBL] [Abstract][Full Text] [Related]
3. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
[TBL] [Abstract][Full Text] [Related]
4. miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells.
Yang Z; Wang XL; Bai R; Liu WY; Li X; Liu M; Tang H
Br J Cancer; 2016 Sep; 115(6):731-40. PubMed ID: 27537390
[TBL] [Abstract][Full Text] [Related]
5. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH
Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Nuclear Receptor Nur77 by miR-124.
Tenga A; Beard JA; Takwi A; Wang YM; Chen T
PLoS One; 2016; 11(2):e0148433. PubMed ID: 26840408
[TBL] [Abstract][Full Text] [Related]
7. TRPS1 expression in breast angiosarcoma.
Pancsa T; Pósfai B; Schubert A; Almási S; Papp E; Chien YC; Kálmán E; Kovács KA; Kulka J; Varga L; Cserni G; Kuthi L
Virchows Arch; 2024 Jun; ():. PubMed ID: 38902365
[TBL] [Abstract][Full Text] [Related]
8. miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer.
Hwang MS; Yu N; Stinson SY; Yue P; Newman RJ; Allan BB; Dornan D
PLoS One; 2013; 8(6):e66502. PubMed ID: 23776679
[TBL] [Abstract][Full Text] [Related]
9. miR-221/222: promising biomarkers for breast cancer.
Chen WX; Hu Q; Qiu MT; Zhong SL; Xu JJ; Tang JH; Zhao JH
Tumour Biol; 2013 Jun; 34(3):1361-70. PubMed ID: 23529451
[TBL] [Abstract][Full Text] [Related]
10. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.
Wei Y; Lai X; Yu S; Chen S; Ma Y; Zhang Y; Li H; Zhu X; Yao L; Zhang J
Breast Cancer Res Treat; 2014 Sep; 147(2):423-31. PubMed ID: 25007959
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-221 and MicroRNA-222 in Common Human Cancers: Expression, Function, and Triggering of Tumor Progression as a Key Modulator.
Amini S; Abak A; Sakhinia E; Abhari A
Lab Med; 2019 Oct; 50(4):333-347. PubMed ID: 31049571
[TBL] [Abstract][Full Text] [Related]
13. Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals.
Abolhasanzadeh N; Sarabandi S; Dehghan B; Karamad V; Avci CB; Shademan B; Nourazarian A
Front Immunol; 2024; 15():1333563. PubMed ID: 38807590
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications.
Szczepanek J; Tretyn A
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002272
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype.
Tariq M; Richard V; Kerin MJ
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002007
[TBL] [Abstract][Full Text] [Related]
17. Palmitic acid promotes human retinal pigment epithelial cells migration by upregulating miR-222 expression and inhibiting NUMB.
Li F; Lei C; Gong K; Bai S; Sun L
Aging (Albany NY); 2023 Apr; 15(18):9341-9357. PubMed ID: 37566749
[TBL] [Abstract][Full Text] [Related]
18. Identification and comprehensive analysis of epithelial-mesenchymal transition related target genes of miR-222-3p in breast cancer.
Fang Y; Zhang Q; Chen C; Chen Z; Zheng R; She C; Zhang R; Wu J
Front Oncol; 2023; 13():1189635. PubMed ID: 37546414
[TBL] [Abstract][Full Text] [Related]
19. Multiple Fra-1-bound enhancers showing different molecular and functional features can cooperate to repress gene transcription.
Bejjani F; Evanno E; Mahfoud S; Tolza C; Zibara K; Piechaczyk M; Jariel-Encontre I
Cell Biosci; 2023 Jul; 13(1):129. PubMed ID: 37464380
[TBL] [Abstract][Full Text] [Related]
20. MiR‑221 and miR‑222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3.
Kim JY; Jung EJ; Kim JM; Son Y; Lee HS; Kwag SJ; Park JH; Cho JK; Kim HG; Park T; Jeong SH; Jeong CY; Ju YT
Exp Ther Med; 2023 Mar; 25(3):127. PubMed ID: 36845963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
